-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on United Therapeutics, Raises Price Target to $768

Benzinga·11/04/2026 17:53:34
Listen to the news
BTIG analyst Julian Harrison maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $728 to $768.